D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
UDR
UDR
$12.9B
| $500K | ﹤0.01% |
13,689
+6,356
| +87% | +$288K |
|
3127
BJ's Restaurants
BJRI
$1.41B
| $499K | ﹤0.01% |
35,916
-18,854
| -34% | -$606K |
|
3128
RLJ Lodging Trust
RLJ
$1.87B
| $499K | ﹤0.01% |
64,588
-84,723
| -57% | -$1.14M |
|
3129
PUT
Sunrun
RUN
$2.37B
| $499K | ﹤0.01% |
+49,400
| New | +$811K |
|
3130
Horizon Bancorp
HBNC
$1.03B
| $495K | ﹤0.01% |
50,221
+15,745
| +46% | +$241K |
|
3131
PUT
Match Group
MTCH
$8.84B
| $495K | ﹤0.01% |
+7,500
| New | +$551K |
|
3132
Team
TISI
$77.7M
| $495K | ﹤0.01% |
7,620
+4,960
| +186% | +$615K |
|
3133
PUT
KKR & Co
KKR
$89.2B
| $493K | ﹤0.01% |
+21,000
| New | +$603K |
|
|
DMYT.U
3134
DELISTED
dMY Technology Group, Inc. Units, each consisting of one share of Class A Common Stock and one-half
DMYT.U
| $492K | ﹤0.01% |
+50,000
| New | +$501K |
|
3135
HCA Healthcare
HCA
$84.8B
| $491K | ﹤0.01% |
5,461
-776
| -12% | -$100K |
|
|
PRA
3136
DELISTED
ProAssurance
PRA
| $491K | ﹤0.01% |
19,637
+6,210
| +46% | +$187K |
|
3137
KALA BIO
KALA
$11.8M
| $489K | ﹤0.01% |
+22
| New | +$351K |
|
3138
Lakeland Financial Corp
LKFN
$1.52B
| $489K | ﹤0.01% |
13,302
-981
| -7% | -$42.6K |
|
|
SAFE
3139
Safehold
SAFE
$1.19B
| $489K | ﹤0.01% |
9,476
+2,792
| +42% | +$188K |
|
3140
Rush Enterprises Class A
RUSHA
$5.95B
| $488K | ﹤0.01% |
34,423
-34,848
| -50% | -$629K |
|
3141
Golar LNG
GLNG
$4.95B
| $487K | ﹤0.01% |
61,839
+49,470
| +400% | +$543K |
|
|
DNKN
3142
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $485K | ﹤0.01% |
9,134
-120,906
| -93% | -$8.38M |
|
3143
Archrock
AROC
$6.33B
| $484K | ﹤0.01% |
128,748
-51,795
| -29% | -$374K |
|
3144
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
| $484K | ﹤0.01% |
6,875
-3,400
| -33% | -$267K |
|
3145
Abeona Therapeutics
ABEO
$345M
| $483K | ﹤0.01% |
9,195
-1,123
| -11% | -$75K |
|
3146
CALL
Arrowhead Research
ARWR
$12.1B
| $483K | ﹤0.01% |
16,800
+1,700
| +11% | +$68.6K |
|
3147
PUT
Williams Companies
WMB
$90.5B
| $481K | ﹤0.01% |
34,000
-83,500
| -71% | -$1.62M |
|
3148
Biglari Holdings Class B
BH
$1.2B
| $480K | ﹤0.01% |
9,334
-5,597
| -37% | -$550K |
|
3149
Grupo Aval
AVAL
$5.67B
| $479K | ﹤0.01% |
109,244
-81,918
| -43% | -$615K |
|
3150
PUT
Snap-on
SNA
$20.9B
| $479K | ﹤0.01% |
+4,400
| New | +$650K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.